EUCTR2015-004129-15-ES进行中（未招募）1 期
Evaluation of [18F] florbetaben in subjects participating in the Parkinson?s Progression Markers Initiative (PPMI) Protocol
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects included in the PPMI protocol:
- •prodromal PD patients
- •age above 60
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •Any contraindication to have a PET scan performed
- •Known intolerance to the PET tracer [18F] florbetaben and/or its excipients
- •Not having given a separate written informed consent for the PET scanning with [18F] florbetaben
- •Pregnant or lactating
研究者
相似试验
进行中（未招募）
不适用
To test the effectiveness of florbetapir (18F) as a diagnostic tool in subjects particpiating in the IRCCS-FBF protocolEUCTR2012-003079-20-ITAVID RADIOPHARMACEUTICALS, INC.
招募中
Unknown
Investigations into the influence of fludarabine exposure on the outcomeof patients after CAR-T cell therapyC90C83Multiple myeloma and malignant plasma cell neoplasmsNon-follicular lymphomaDRKS00033974niversitätsklinikum Hamburg Eppendorf200
招募中
不适用
Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCTHead and Neck Cancer,Malignant gliomaJPRN-UMIN000035976Southern TOHOKU BNCT Research Center20
已完成
1 期
[18F]-tetrafluoroborate in patients with primary thyroid cancer or salivary cancerTopic: CancerSubtopic: Head and Neck CancerDisease: Head and NeckCancerThyroid carcinomaISRCTN75827286King's College London5
终止
4 期
Cardiac Uptake of 18F Florbetapir in Patients Undergoing ChemotherapyCardiac AmyloidosisNCT03333551Medical College of Wisconsin4